13 set 2017 ano - Potential for use of macrocyclic peptide encompassing
the L2 loop sequence from HHIP to disrupt SHH binding
as a therapy.
Descrição:
Design and Evolution of a Macrocyclic Peptide Inhibitor of the Sonic Hedgehog pathway
Adicionado na linha do tempo:
Data:
~ 6 years and 8 months ago